Trial intelligence / Profile preview

Tacrolimus Ointment in Adult Patients With Moderate to Severe Atopic Dermatitis

NCT01828879Phase 4Completed

Sponsor
Janssen Pharmaceutical
Start
Nov 2007
Primary completion
Jun 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Tacrolimus Ointment 0.1% Iwaki in atopic dermatitis (AD), sponsored by Janssen Pharmaceutical. Started Nov 2007; status: completed.

02

Drugs

Tacrolimus Ointment 0.1% Iwaki
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT01828879.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01828879.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call